Progress in Anti-SARS Coronavirus Chemistry, Biology and Chemotherapy
- 1 January 2006
- book chapter
- Published by Elsevier
- Vol. 41, 183-196
- https://doi.org/10.1016/s0065-7743(06)41011-3
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Severe acute respiratory syndrome coronavirus papain-like protease: Structure of a viral deubiquitinating enzymeProceedings of the National Academy of Sciences, 2006
- Crystal Structures of the Main Peptidase from the SARS Coronavirus Inhibited by a Substrate-like Aza-peptide EpoxideJournal of Molecular Biology, 2005
- Screening of drugs by FRET analysis identifies inhibitors of SARS-CoV 3CL proteaseBiochemical and Biophysical Research Communications, 2005
- Ribavirin and interferon-β synergistically inhibit SARS-associated coronavirus replication in animal and human cell linesBiochemical and Biophysical Research Communications, 2004
- In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquineBiochemical and Biophysical Research Communications, 2004
- “Teaching old drugs to kill new bugs”: structure-based discovery of anti-SARS drugsBiochemical and Biophysical Research Communications, 2004
- Characterization of SARS main protease and inhibitor assay using a fluorogenic substrateBiochemical and Biophysical Research Communications, 2004
- HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirusBiochemical and Biophysical Research Communications, 2004
- Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 LineagePublished by Elsevier ,2003
- Comparative Adverse Effect Profiles of Platinum DrugsDrug Safety, 1995